Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Colinz Laboratories Ltd ("Target ....

Saffron Capital Advisors Private Limited 304, A Wing, 215 Atrium, M V Road, Chakala, Andheri East, Mumbai-400093 Tel.: +91-22-49730394 Email: info@saffronadvisor.com Website: www.saffronadvisor.com CIN No.: U67120MH2007PTC166711 July 31, 2026 Listing Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400 001 Scrip Code: 531210 Dear Sir/Madam, Sub: Open Offer by Annjana Dugar (“Acquirer 1”), Likhitta Dugar (“Acquirer 2”) and Antariksh Dugar (“Acquirer 3”) (Hereinafter Acquirer 1, Acquirer 2 and Acquirer 3 collectively referred to as "Acquirers") Together with Padam Dugar (“Person Acting In Concert” or “PAC”), to acquire up to 6,54,966 (Six Lakh Fifty Four Thousand Nine Hundred and Sixty Six) fully paid-up Equity Shares of face value of ₹ 10/- (Rupees Ten only) each for cash at a price of ₹ 54/- (Rupees Fifty Four only) per Equity Shares aggregating up to ₹ 3,53,68,164/- (Rupees Three Crore Fifty Three Lakh Sixty Eight Thousand One Hundred Sixty Four Only), representing 26% (Twenty Six Percent) of the Voting Share Capital of the Target Company, to the Public Shareholders of Colinz Laboratories Limited (“Target Company”) pursuant to and in compliance with the requirements of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended (“SEBI (SAST) Regulations, 2011”) (“Offer” Or “Open Offer”). We have been appointed as ‘Manager’ to the captioned Open Offer by the Acquirers and the PAC in terms of Regulation 12(1) of the SEBI (SAST) Regulations, 2011. In this regard, we are enclosing a copy of Letter of Offer dated July 29, 2026 (“LOF”) the following for your kind reference and records: We request you to kindly consider the attachments as good compliance and disseminate it on your website. In case of any clarification required, please contact the person as mentioned below: Contact Person Designation Contact Number E-mail Id Saurabh Gaikwad Senior Manager and Assistant saurabh@saffronadvisor.com Compliance Officer +91 22 49730394 Shivam Sharma Assistant Manager shivam@saffronadvisor.com For Saffron Capital Advisors Private Limited Saurabh Gaikwad Senior Manager and Assistant Compliance Officer Equity Capital Markets Encl: a/a Registered Office: 605, Sixth Floor, Centre Point, J B Nagar, Andheri East, Mumbai-400059/ SEBI Registration No: INM000011211 LETTER OF OFFER (“LOF”) THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION This Letter of Offer is being sent to you as a Public Shareholder (as defined below) of Colinz Laboratories Limited (“Target Company”). If you require any clarifications about the action to be taken, you may consult your stockbroker or an investment consultant or the Manager to the Offer (as defined below) or the Registrar to the Offer (as defined below). In the event you have recently sold your Equity Shares (as defined below) in the Target Company, please hand over the Letter of Offer and the accompanying Form of Acceptance-cum-Acknowledgement to the purchaser of the Equity Shares or the member of the stock exchange through whom the said sale was effected. OPEN OFFER (“OPEN OFFER”/ “OFFER”) BY Annjana Dugar (“Acquirer 1”) having Residential Address at: 1(3A), College Lane, Thousand Lights, Greams Road, PO: Greams Road - 600006 Dist: Chennai, Tamilnadu, India; Tel: +91 9884086767; Email: annjanad@yahoo.com; Likhitta Dugar (“Acquirer 2”) having Residential Address at: 1(3A), College Lane, Thousand Lights, Greams Road, PO: Greams Road - 600006 Dist: Chennai, Tamilnadu, India; Tel: +91 9884086767; Email: likhitta.work@gmail.com; Antariksh Dugar (“Acquirer 3”) having Residential Address at: 1(3A), College Lane, Thousand Lights, Greams Road, PO: Greams Road - 600006 Dist: Chennai, Tamilnadu, India ; Tel: +91 9884086767; Email: antarikshwork@icloud.com; Padam Dugar (“Person Acting in Concert” OR “PAC”) having Residential Address at: 1(3A), College Lane, Thousand Lights, Greams Road, PO: Greams Road - 600006 Dist: Chennai, Tamilnadu, India; Tel: +91 9884086767; Email: padamdt@yahoo.com; To the Eligible Shareholder(s) of Colinz Laboratories Limited (“Target Company”) having Registered Office at: A-101, Pratik Industrial Estate, Mulund Goregaon Link Road, Bhandup West, 400078, Mumbai, Maharashtra, India Tel: +91-9667682666; Email: cllfindoc@yahoo.com; Website: www.colinz.com; Corporate Identification Number: L24200MH1986PLC041128; to acquire up to 6,54,966 (Six Lakh Fifty Four Thousand Nine Hundred and Sixty Six) fully paid up Equity Shares of face value of ₹ 10/- each (“Offer Shares”) representing 26% (Twenty Six Percent) of the Voting Share Capital (defined below) of the Target Company, for cash at a price of ₹ 54/- (Rupees Fifty Four Only) per Equity Share (“Offer Price”). Please Note: 1. This Offer is being made by the Acquirers and the PAC to the Public Shareholders of the Target Company pursuant to and in compliance with Regulations 3(1) and 4 of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereto (“SEBI (SAST) Regulations, 2011”) for substantial acquisition of shares and voting rights accompanied with change in control. 2. This Offer is not conditional upon any minimum level of acceptance in terms of Regulation 19(1) of the SEBI (SAST) Regulations, 2011. 3. This Offer is not a competing offer in terms of Regulation 20 of the SEBI (SAST) Regulations, 2011. 4. As per the information available with the Acquirers, PAC and the Target Company, there has been no competing offer as on the date of this Letter of Offer. The last date for making such competing offer has expired. 5. As on the date of this Letter of Offer, there are no statutory approvals required by the Acquirers and the PAC to complete the underlying transaction and this Open Offer. In case any statutory approvals are required or become applicable at a later date before the closure of the Tendering Period, this Open Offer shall be subject to the receipt of such statutory approvals. 6. As on date of this Letter of Offer, the marketable lot for the Equity Shares of the Target Company is 1 (One). 7. In terms of Regulation 23 of the SEBI (SAST) Regulations, 2011, in the event that the approvals specified in Section IX (B) (Statutory and Other Approvals) of this LOF or those which become applicable prior to completion of the Open Offer are not received, for reasons outside the reasonable control of the Acquirers and the PAC, then the Acquirers and the PAC shall have the right to withdraw the Open Offer. The following conditions under which the Acquirers and the PAC can withdraw the Open Offer, as provided in Regulation 23(1) of the SEBI (SAST) Regulations, 2011, are: i. statutory approvals required for the Open Offer or for effecting the acquisitions attracting the obligation to make an Open Offer under these regulations having been finally refused, subject to such requirements for approval having been specifically disclosed in the detailed public statement and the letter of offer; ii. the Acquirer(s) and the PAC, being a natural person, has died; iii. any condition stipulated in the agreement for acquisition attracting the obligation to make the Open Offer is not met for reasons outside the reasonable control of the Acquirers and the PAC, and such agreement is rescinded, subject to such conditions having been specifically disclosed in the detailed public statement and the letter of offer, provided that Acquirers and the PAC shall not withdraw the Open Offer pursuant to a public announcement made under clause (g) of sub-regulation (2) of regulation 13, even if the proposed acquisition through the preferential issue is not successful but subject to paragraph 7(i) above; or iv. such circumstances as in the opinion of the Board, merit withdrawal. In the event of such a withdrawal of the Open Offer, a public announcement will be made within 2 (Two) Working Days of such withdrawal, in the same newspap [Showing first 8,000 characters — download PDF for full document]